Acer Therapeutics Inc (NASDAQ:ACER)

2.05
Delayed Data
As of Jan 18
 -0.16 / -7.24%
Today’s Change
1.68
Today|||52-Week Range
5.39
-10.09%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Acer Therapeutics Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 10.00. The median estimate represents a +436.59% increase from the last price of 2.05.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Acer Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.25
Sales
$0.00
Reporting Date
Mar 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -8.70%
 
 
 
 
 
 
Growthannually 50.49%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.